References
- Todd J, Fishaut M. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978: 2 (8100):1116–8
- Stevens FA. The occurrence of Staphylococcus aureus infection with a scarlatiniform rash. JAMA 1927: 88(25):1957–8
- Schlievert PM, Schoettle DJ. Watson DW. Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun 1979: 23(3):609–17
- Centers for Disease Control. Toxic-shock syndrome—United States. 1970–1982. Morbid Mortal Weekly Rep 1982: 31(16):201–4
- Osterholm MT. Forfang JC. Surveillance of toxic shock syndrome in Minnesota: comments on national surveillance. Ann Intern Med 1982 36(6 Pt 2):887–90
- Reingold AL, Hargrett NT, Shands KN, et al. Toxic shock syndrome surveillance In the United States. 1980 to 1981. Ann Intern Med 1982: 96(6 Pt 2):875–80
- Osterholm MT, Forfang JC. Toxic-shock syndrome in Minnesota: results of an active-passive surveillance system. J Infect Dis 1982: 145(4):458–64
- Reingold AL, Hargrett NT, Dan BB, et al. Non- menstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 1982: 96(6 Pt 2):871–4
- Tofte RW. Williams DN. Toxic shock syndrome: clinical and laboratory features in 15 patients. Ann Intern Med 1981: 94(2):149–56
- Reingold AL, Shands KN, Dan BB, et al. Toxic-shock syndrome not associated with menstruation. Lancet 1982: 1:1–4
- Osterholm MT, Davis JP, Gibson RW, et al. Tristate toxic-shock syndrome study. I. Epidemiologic findings. J Infect Dis 1982: 145(4):431–40
- Tofte RW, Williams DN. Clinical and laboratory manifestations of toxic shock syndrome. Ann Intern Med 1982: 96(6 Pt 2):843–7
- Davis JP, Chesney PJ, Wand PJ, et al. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors and prevention. N Engl J Med 1980: 303(25):1429–35
- Shands KN, Schmid GP, Dan BB, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features In 52 cases. N Engl J Med 1980: 303(25):1436–42
- Davis JP, Osterholm MT, Helms CM, et al. Tristate toxic shock syndrome study. II. Clinical and laboratory findings. J Infect Dis 1982: 145(4):441–8
- Schlievert PM, Shands KN, Dan BB, et al. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 1981: 143(4):509–16
- Bergdoll MS, Crass BA. Reiser RF, et al. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock syndrome Staphylococcus aureus Isolates. Lancet 1981: 1(8228):1017–21
- Tofte RW, Williams DN. Toxic shock syndrome: evidence of abroad clinical spectrum. JAMA 1981: 246(19):2163–7
- Chesney PJ, David JP, Purdy WK, et al. Clinical manifestations of toxic shock syndrome. JAMA 1981: 246(7):741–8
- Fisher RF, Goodpasture HC, Peterie JD, et al. Toxic shock syndrome in menstruating women. Ann Intern Med 1981: 94(2):156–63
- McKenna UG, Meadows JA 3d, Brewer NS, et al. Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. Mayo Clin Proc 1980: 55 (11):663–72
- Chesney PJ, Crass BA, Polyak MB, et al. Toxic shock syndrome: management and long-term sequelae. Ann Intern Med 1982: 96(6 Pt 2):847–51